| Literature DB >> 28517984 |
Kezia Gaitskell1,2.
Abstract
One of the promised benefits of 'personalised' medicine is that it will have a positive impact on disease screening and prevention, by enabling more person-specific estimates of risk, and hence more personalised strategies for screening and risk reduction. This article summarises some of the areas in which these approaches are already being implemented, but also outlines some of the potential difficulties and limitations - and challenges the assumption that 'personalised' approaches are necessarily superior for prevention and screening.Entities:
Keywords: epidemiology; genetic testing; personalised medicine; prevention; risk reduction; screening
Mesh:
Year: 2017 PMID: 28517984 DOI: 10.1080/20502877.2017.1314884
Source DB: PubMed Journal: New Bioeth ISSN: 2050-2877